Image of intestines with a cropped circle showing a close up view of microrganisms in the microbiome. There is also another cropped circle with a magnifying glass examining data. TrialNet logo is in the top left corner.
Research Spotlight
Read more
Exploring the fascinating connection between the gut microbiome and immune therapy
While conducting research in his lab at Yale University, TrialNet Chair Kevan Herold, MD, discovered an interesting outcome. Mouse models (mice genetically modified to mimic a human condition) treated with multiple antibiotics did not respond to the immune therapy teplizumab, the only FDA-approved treatment to delay the onset of type 1 diabetes (T1D).
Lisa Gier in the foreground wearing a Camp Hodia shirt with a lake and snow-capped mountain in the background
Media Release
Read more
TrialNet Partner Spotlight: Diabetes Education & Camping Association Executive Director Lisa Gier
From camper to director of the largest camping association serving people with diabetes
When Lisa Gier attended her first diabetes camp at Camp Hodia (a mix of Idaho and diabetes) at age 10, she had no idea she would build an amazing career in camping.
4 poloroid photos of maisie on a blue and pink background. Maisie celebrates wearing a pump and cgm in the first photos. The last photos feature Maisie's Diabetes Link chapter and a Diabuddy stuffed animal.
Participant Spotlight
Read more
Meet Maisie Mische: Turning a T1D diagnosis into opportunities
When Maisie Mische, a 22-year-old mechanical engineering student at Marquette University, started having trouble with her vision last year, she attributed the problem to eye fatigue from late-night studying. But two episodes of double vision and subsequent tests revealed something more complex: type 1 diabetes (T1D).
Sign up here to join our mailing list for the latest updates on important T1D research and events, straight to your inbox. You can also find us on Facebook @DiabetesTrialNet.
